| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/12/2004 | CA2494310A1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/12/2004 | CA2494214A1 Conjugates of porphyrin compounds with chemotherapeutic agents |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/12/2004 | CA2493752A1 Papsss as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493637A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | CA2493618A1 Nitrosated proton pump inhibitors, compositions and methods of use |
| 02/12/2004 | CA2493253A1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 02/11/2004 | EP1388542A1 Use of hederagenin 3-0-alpha-L-rhamnopyranosyl(1-2[beta-D-glucopyranosyl(1-4)]-alpha-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors |
| 02/11/2004 | EP1388541A1 Pyrrolopyrazines as kinase inhibitors |
| 02/11/2004 | EP1388534A2 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 02/11/2004 | EP1388343A1 Antioxidant composition and method of preparation thereof |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387886A2 Proteases |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/11/2004 | EP1387844A1 Retinol derivatives potentiation of active substances by micellar preparation |
| 02/11/2004 | EP1387840A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors |
| 02/11/2004 | EP1387838A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 02/11/2004 | EP1387836A1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1387701A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
| 02/11/2004 | EP1387694A2 Composition and method for treating cancer using herpes virus |
| 02/11/2004 | EP1387690A1 Use of extracts and preparations from iris plants and tectorigenin as medicaments |
| 02/11/2004 | EP1387689A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 02/11/2004 | EP1387688A2 Benzazepinone alpha v integrin receptor antagonists |
| 02/11/2004 | EP1387684A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents |
| 02/11/2004 | EP1387683A1 Novel salt and crystalline forms of (2r)-anti-5-3-(4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypropoxy quinoline |
| 02/11/2004 | EP1387680A1 Benzimidazole derivatives as therapeutic agents |
| 02/11/2004 | EP1387677A2 Method of treating hematologic tumors and cancers using beta lapachone |
| 02/11/2004 | EP1387674A2 Hedgehog antagonists, methods and uses related thereto |
| 02/11/2004 | EP1240157B1 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 02/11/2004 | EP1227795B1 Lipid complex of alkycyclines |
| 02/11/2004 | EP1083937B1 Radioioinated phenols for brachytherapy |
| 02/11/2004 | EP1047411B1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 02/11/2004 | EP1020462B1 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 02/11/2004 | EP0936912B1 Inhibitors of cysteine protease |
| 02/11/2004 | EP0909177B1 Aqueous formulations of peptides |
| 02/11/2004 | EP0892640B1 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
| 02/11/2004 | EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 02/11/2004 | EP0835124B1 Serum preparations for inhibiting retroviruses and tumor growth |
| 02/11/2004 | EP0832094B1 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 02/11/2004 | EP0804482B1 Cytokines that bind the cell surface receptor hek |
| 02/11/2004 | EP0797567B1 Novel amino acid derivatives with improved multi-drug resistance activity |
| 02/11/2004 | CN1474871A Inhibitor proteins |
| 02/11/2004 | CN1474822A Novel 4'-demethyl-4'-0-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for preparation thereof and anti-cancer composition comprising same |
| 02/11/2004 | CN1474821A New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 02/11/2004 | CN1474819A Novel imidazole derivatives, production method thereof and use thereof |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/11/2004 | CN1474809A Cyanopyrolidine derivatives |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474797A Retiferol derivatives and their use in treatment of skin diseases or conditions associated with photodamage |
| 02/11/2004 | CN1474703A Taxoid conjugates as antimitotic and antitumor agents |
| 02/11/2004 | CN1474693A Use of thienopyrimidines |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1474685A Polymeric delivery formulations of leuprolide with improved efficacy |
| 02/11/2004 | CN1473926A Sulfated NF1 granulose-anti-AIDS medicine and its preparing method |
| 02/11/2004 | CN1473848A Anti-tumor activity of Luffa acutangula 2 and its use |
| 02/11/2004 | CN1473847A Glycosidase activity of Luffa acutangula, and its use |
| 02/11/2004 | CN1473837A Stem clasping gut weed lactone and its derivative composition and its preparing method and its use |
| 02/11/2004 | CN1473827A 3-position substituted quinolone derivativers and its use in pharmacy |
| 02/11/2004 | CN1473620A Capsule of cordyceps |
| 02/11/2004 | CN1473615A Use of pulse-activating injection in preparing synergetic medicine for treating tumor |
| 02/11/2004 | CN1473614A Chinese medicine for treading apoplexy, cancer and other diseases |
| 02/11/2004 | CN1473610A Medicine for treating cancer |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 02/11/2004 | CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/11/2004 | CN1137883C Aromatic carboxylic acid ester, its production and use of same as medicaments |
| 02/11/2004 | CN1137721C Chinese medicinal injection for treating liver cancer and carcinoma of large intestine |
| 02/11/2004 | CN1137709C Cancer treating capsule and its preparing method |
| 02/10/2004 | US6689922 Vitamin D analogues |
| 02/10/2004 | US6689886 Treatment of inflammation and other immune disorders |
| 02/10/2004 | US6689871 Process for production diphtheria toxin |
| 02/10/2004 | US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same |
| 02/10/2004 | US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity |
| 02/10/2004 | US6689810 Contacting mammalian cells with nitric oxide mediator, wherein nitric oxide mediator is selected from pyruvates, pyruvate precursors, alpha -keto acids having four or more carbon atoms, precursors of alpha -keto acids for therapy |
| 02/10/2004 | US6689805 Treatment of pain, inflammation, fever, cancer and dementia |
| 02/10/2004 | US6689802 Polymorphs of an epothilone analog |
| 02/10/2004 | US6689798 Benzofuran derivatives |
| 02/10/2004 | US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689784 Controlling cell apoptosis |
| 02/10/2004 | US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689769 Bactericides |
| 02/10/2004 | US6689598 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/10/2004 | US6689597 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 02/10/2004 | US6689570 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 02/10/2004 | US6689561 Isolated cdk4i gene (cdk4i=cyclin-dependent kinase 4 inhibitor), in which deletions or polymorphisms have been shown to cause susceptibility to certain cancers; detecting deletions or polymorphisms; kits, diagnosis |
| 02/10/2004 | US6689400 Sovent extracting the dried marigold flower petals, eluting through an anion exchange resin column, diluting the eluent, crystallization; protecting lutein against deterioration, store for long time |
| 02/10/2004 | US6689398 Triterpene compositions and methods for use thereof |
| 02/10/2004 | US6689381 Liposome comprising phosphatidylcholine, cholesterol, as well as benzoquinazoline thymidylate synthase inhibitor; improved pharmacokinetics and efficacy as anti-tumor agents compared to free drug |
| 02/10/2004 | US6689362 Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP) |
| 02/10/2004 | US6689359 Ligands, including antibodies, showing reactivity against endocrine cells |